Challenges and opportunities in the immunotherapy era: balancing expectations with hope in small-cell lung cancer
Small-cell lung cancer (SCLC) is a biologically aggressive subtype of lung cancer, a lethal disease characterized by rapid tumor growth, early relapse, a strong tendency for early widespread metastasis, and high genomic instability, making it a formidable foe in modern oncology practice.While the management of non-SCLC has been revolutionized in th